|
Pharmacotherapy: A Pathophysiologic Approach, 7e
4/28/2010: Tocilizumab: Novel Second-Line Treatment Approved for Rheumatoid Arthritis
Maria G. Tanzi
Clinical Assistant Professor, University of Illinois at Chicago College of Pharmacy
Topics Discussed: antirheumatic drugs, disease-modifying; interleukin-6; methotrexate; monoclonal antibodies; pharmacotherapy of bone and joint disorders; rheumatoid arthritis.
Related to Chapter 94. Rheumatoid Arthritis; View in chapter;
Excerpt:
"View in chapter..."
|
|
|
|
|